Covered recipient · General Payments record
JOEL J KASSIMIR
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$7,266.97
- Reported across 254 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $882.93 | 38 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | $541.82 | 7 |
| ABBVIE INC. | $254.29 | 27 |
| PFIZER INC. | $49.81 | 2 |
| Lilly USA, LLC | $20.86 | 1 |
| Galderma Laboratories, L.P. | $16.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (38)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.21 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037317 | CMS |
| ABBVIE INC. | $2.81 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037319 | CMS |
| ABBVIE INC. | $8.58 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037321 | CMS |
| ABBVIE INC. | $0.91 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037323 | CMS |
| ABBVIE INC. | $6.35 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037325 | CMS |
| ABBVIE INC. | $0.66 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037327 | CMS |
| ABBVIE INC. | $1.09 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037329 | CMS |
| ABBVIE INC. | $14.77 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037331 | CMS |
| ABBVIE INC. | $17.76 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037333 | CMS |
| ABBVIE INC. | $3.11 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037335 | CMS |
| ABBVIE INC. | $18.60 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037337 | CMS |
| ABBVIE INC. | $1.87 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037339 | CMS |
| ABBVIE INC. | $0.91 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037341 | CMS |
| ABBVIE INC. | $4.60 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037343 | CMS |
| ABBVIE INC. | $14.94 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037345 | CMS |
| ABBVIE INC. | $15.04 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037347 | CMS |
| ABBVIE INC. | $18.95 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037349 | CMS |
| ABBVIE INC. | $1.00 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037351 | CMS |
| ABBVIE INC. | $19.95 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037353 | CMS |
| ABBVIE INC. | $0.93 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037355 | CMS |
| ABBVIE INC. | $17.89 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037357 | CMS |
| ABBVIE INC. | $5.15 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037359 | CMS |
| ABBVIE INC. | $2.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037361 | CMS |
| ABBVIE INC. | $13.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037363 | CMS |
| ABBVIE INC. | $6.59 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037365 | CMS |
| ABBVIE INC. | $18.91 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037367 | CMS |
| ABBVIE INC. | $21.29 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104037369 | CMS |
| Galderma Laboratories, L.P. | $16.15 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145308005 | CMS |
| Lilly USA, LLC | $20.86 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135069089 | CMS |
| PFIZER INC. | $27.05 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131334175 | CMS |
| PFIZER INC. | $22.76 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131854731 | CMS |
| REVANCE THERAPEUTICS, INC. | $434.72 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921512 | CMS |
| REVANCE THERAPEUTICS, INC. | $1.25 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921514 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.23 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921516 | CMS |
| REVANCE THERAPEUTICS, INC. | $30.11 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921518 | CMS |
| REVANCE THERAPEUTICS, INC. | $18.12 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921520 | CMS |
| REVANCE THERAPEUTICS, INC. | $1.38 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921522 | CMS |
| REVANCE THERAPEUTICS, INC. | $26.01 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147921524 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.